Aratana Therapeutics 10Q 2015 Q1 Quarterly report | PETX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: accuracy, Additionally, agonist, alphabet, Arrangement, awaiting, binding, bupivacaine, California, cancellable, capacity, capromorelin, client, Cloud, CMC, committed, compassionate, conclusion, confidential, consent, contaminant, contractual, CVM, depletion, Derecognition, destroyed, detected, directly, discovery, DMF, documentation, dozen, driven, enhance, environmental, epilepsy, explore, exploring, external, ghrelin, grapiprant, Greek, hemangiosarcoma, hosted, identification, implement, ineffective, injectable, inspection, instability, institution, intend, intended, knee, larger, launch, liposome, litigation, lot, master, mechanism, melanoma, misstatement, misuse, mitigate, occasionally, periodontal, policy, predetermined, prospectively, prostaglandin, reacquire, reclassified, reduction, release, remediate, remediating, remediation, restatement, seed, serial, Simplifying, software, specialty, stimulation, supply, surgery, suspension, undergoing, undisclosed, updated

Removed: academia, accelerated, acceptable, account, accreted, Accretion, adequate, administration, allocate, amendment, amortizing, arise, arising, arriving, assembled, assessed, assure, atopic, August, Authority, began, biology, Bioscience, board, borrowed, borrowing, Canada, certificate, chemistry, choosing, chosen, close, closed, committee, compliance, compound, consulting, consummate, consummation, continuation, contracted, convertible, cumulative, currency, curtail, decided, declared, default, demonstrated, description, detailed, developed, directed, director, Dollar, drop, effected, eligibility, eligible, employee, encumber, entitled, entity, equal, equivalent, exceed, execution, exemption, expertise, exposed, favorable, fee, feline, filing, final, finalization, fixed, formulation, fractional, frequently, functional, funded, generate, greater, Heartland, holding, House, immunodeficiency, improved, Incorporation, induced, ingredient, initiated, insolvency, internally, investigating, IPO, issuer, joint, KBA, lease, leased, lender, length, leverage, LLC, lower, manner, margin, monthly, MPM, multiple, November, obligated, obtaining, occurrence, office, ophthalmic, opportunity, originally, Pacira, par, parallel, parking, partial, peer, permanent, Pharma, pharmaceutical, Phase, placement, potentially, practicable, preferred, preliminarily, preliminary, President, professional, projected, protection, quality, RaQualia, ratio, recognize, recovery, regularly, reimbursement, relation, relinquish, remain, remained, rent, reorganization, repaid, request, requirement, researching, residual, retroactively, revision, royalty, safely, scheduled, securing, seek, September, shared, significantly, Simultaneously, space, split, Square, stated, steering, stockholder, subsidiary, substantially, successfully, supplement, temporary, term, track, translated, translation, travel, treasury, ultimately, unable, unaffiliated, unaltered, underpin, underwriting, unrestricted, upfront, vesting, viability, voting, voucher, wholly, withheld, withholding, work

Aratana Therapeutics (PETX) Inactive 10-Q2015 Q1 Quarterly report

Content analysis